Ontario Drug Benefit Act, R.S.O. 1990, c. O.10
Section 19
Decisions about listing, delisting
Cite as Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, s. 19 · current to November 11, 2026 · consolidated from January 1, 2022 · read from e-Laws on November 17, 2026
The text
In deciding whether or not to designate a drug product as a listed drug product or to remove such a designation, the executive officer may consider anything he or she considers advisable in the public interest, including, without limiting the generality of the foregoing, the drug benefit price of the drug product or other drug products or the price charged to operators of pharmacies for the drug product or other drug products. 2006, c. 14, s. 28.
Read the Ontario Drug Benefit Act on e-Laws ↗